Qvar 50 inhaler

Kraj: Wielka Brytania

Język: angielski

Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)

Składnik aktywny:

Beclometasone dipropionate

Dostępny od:

DE Pharmaceuticals

Kod ATC:

R03BA01

INN (International Nazwa):

Beclometasone dipropionate

Dawkowanie:

50microgram/1dose

Forma farmaceutyczna:

Pressurised inhalation

Droga podania:

Inhalation

Klasa:

No Controlled Drug Status

Typ recepty:

Caution - AMP level prescribing advised

Podsumowanie produktu:

BNF: 03020000

Ulotka dla pacjenta

QVAR® EASI-BREATHE® 50 MICROGRAMS PER ACTUATION INHALER
QVAR® EASI-BREATHE® 100 MICROGRAMS PER ACTUATION INHALER
BECLOMETASONE DIPROPIONATE
PACKAGE LEAFLET: INFORMATION FOR THE USER
READ ALL OF THIS LEAFLET
CAREFULLY BEFORE
YOU START USING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT
INFORMATION FOR YOU.
●
Keep this leaflet. You
may need to read it
again.
●
If you have any
further questions,
ask your doctor or
pharmacist.
●
This medicine has
been prescribed for
you only. Do not pass
it on to others. It may
harm them, even if
their signs of illness
are the same as yours.
●
If you get any side
effects, talk to your
doctor or pharmacist.
This includes any
possible side effects not
listed in this leaflet. See
section 4.
WHAT IS IN THIS LEAFLET
1.
What Qvar Easi-Breathe Inhaler is and what it is
used for
2.
What you need to know before you use Qvar Easi-
Breathe Inhaler
3.
How to use Qvar Easi-Breathe Inhaler
4.
Possible side effects
5.
How to store Qvar Easi-Breathe Inhaler
6.
Contents of the pack and other information
1. WHAT QVAR EASI-BREATHE INHALER IS AND
WHAT IT IS USED FOR
Qvar Easi-Breathe Inhaler contains beclometasone
dipropionate, which belongs to a group of medicines
known as corticosteroids.
Qvar Easi-Breathe Inhaler is used to prevent the
symptoms of mild, moderate, or severe asthma in
patients who require regular treatment.
HOW YOUR MEDICINE WORKS
●
Qvar Easi-Breathe Inhaler works deep in your lungs to
make breathing easier by reducing the inflammation,
swelling, and irritation in the airways. This type of
medicine is known as a ‘preventer’. It needs to be taken
regularly every day, even if you have no symptoms.
●
This inhaler will not give immediate relief of
wheezing or breathlessness during a sudden asthma
attack. You will need to use a ‘reliever’ inhaler,
which contains a different medicine. You should still
continue to use this inhaler.
●
you are suffering from a sudden attack of
breathlessness. It will not help. Use a quick-acting
‘reliever’ inhaler for this purpose an

Charakterystyka produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Qvar
®
Easi-Breathe
®
50
micrograms
per
actuation
pressurised
inhalation
solution
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Pressurised inhalation, solution
A
colourless
solution
in
a
pressurised
aluminium
canister
fitted
with
a
metering valve and an actuator.
Qvar
Easi-Breathe
contains
a
propellant,
which
does
not
contain
any
chlorofluorocarbons (CFCs).
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Prophylactic management of mild, moderate or severe asthma.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Qvar Easi-Breathe is for inhalation use only.
Patients should be instructed in the proper use of their inhaler,
including rinsing out
their mouth with water after use..
NOTE: THE RECOMMENDED TOTAL DAILY DOSE OF QVAR EASI-BREATHE IS LOWER
THAN
THAT FOR CURRENT BECLOMETASONE DIPROPIONATE CONTAINING PRODUCTS AND
SHOULD BE
ADJUSTED TO THE NEEDS OF THE INDIVIDUAL PATIENT.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise
pulmonary function
as soon as possible. When patients’ symptoms remain under
satisfactory control, the
dose should be titrated to the lowest dose at which effective control
of asthma is
maintained.
To be effective inhaled Qvar Easi-Breathe must be used on a regular
basis even when
patients are asymptomatic.
THERAPY IN NEW PATIENTS SHOULD BE INITIATED AT THE FOLLOWING
Mild asthma:
100 to 200 micrograms per day in two divided doses.
Moderate asthma:
200 to 400 micrograms per day in two divided doses.
Severe asthma:
400 to 800 micrograms per day in two divided doses.
Patients on budesonide inhalers may be transferred to Qvar as
described below
The general approach to switching patients to Qvar involves two steps
as detailed
below. Specific guidance on switching well-controlled and
poorly-controlled
(symptomatic) patients is given below